发明授权
US07157268B2 Process for producing L-epi-2-inosose and novel process for producing epi-inositol using microorganisms
失效
利用微生物生产外延蛋白-2-inosose的方法和生产表肌醇的新方法
- 专利标题： Process for producing L-epi-2-inosose and novel process for producing epi-inositol using microorganisms
- 专利标题（中）： 利用微生物生产外延蛋白-2-inosose的方法和生产表肌醇的新方法
-
申请号： US10852153申请日： 2004-05-25
-
公开(公告)号： US07157268B2公开(公告)日： 2007-01-02
- 发明人: Atsushi Takahashi , Kenji Kanbe , Tetsuya Mori , Yuichi Kita , Tsuyoshi Tamamura , Tomio Takeuchi
- 申请人： Atsushi Takahashi , Kenji Kanbe , Tetsuya Mori , Yuichi Kita , Tsuyoshi Tamamura , Tomio Takeuchi
- 申请人地址： JP Tokyo JP Tokyo
- 专利权人： Hokko Chemical Industry Co., Ltd.,Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai
- 当前专利权人： Hokko Chemical Industry Co., Ltd.,Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai
- 当前专利权人地址： JP Tokyo JP Tokyo
- 代理机构： Stites & Harbison PLLC
- 代理商 B. Aaron Schulman
- 优先权： JP11-159861 19990607; JP11-340523 19991130; JP2000-151709 20000523
- 主分类号： C12P19/02
- IPC分类号： C12P19/02 ; C12N1/20
摘要：
Provided are novel processes for the efficient production of L-epi-2-inosose and epi-inositol which are useful either as various medicines or intermediates for the syntheses of various medicines. In the processes, inexpensive myo-inositol is used as a starting compound which is reacted with a gram-negative bacterium capable of converting myo-inositol into L-epi-2-inosose, and thereby producing L-epi-2-inosose by conversion of myo-inositol into L-epi-2-inosose. A biologically pure culture of Pseudomonas sp. AB 10215 strain is also provided which has a characteristic nature of being capable of converting myo-inositol into L-epi-2-inosose.